The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VTGN · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | VTGN | GEOS | STEX | ONCO |
|---|---|---|---|---|
| Moat Score (0–100) | 34 | 35 (highest) | 35 (highest) | 34 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 38 | 50 (highest) | 30 | 50 (highest) |
| Pricing power | — | 16 | 71 (highest) | 42 |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 28 | 28 |
| Capital discipline | 44 | 52 | 44 | 53 (highest) |
| Price vs. high estimate | No price data | 128% above high estimate | No price data | No price data |
| Market cap | $9.5M | $89.5M | $39.8M | $1.3M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2026 | FY2025 | FY2025 | FY2025 |